Recent data suggest that the target cells for initial oncogenic hit in fetal MLL-AF4+ may be mesodermal pre-hematopoietic cells or hemangioblasts [38], [39] rather than more committed HSC/progenitor cells generally assumed as target cells for pediatric TEL-AML1+ B-ALL. Here, RUNX1 is linked to acute lymphoblastic leukemia.